2005
DOI: 10.1038/sj.pcan.4500844
|View full text |Cite
|
Sign up to set email alerts
|

The link between obesity and prostate cancer: the leptin pathway and therapeutic perspectives

Abstract: Obesity-associated prostate cancer (PCa) remains controversial, although most studies rely on body mass index evaluation, which is an indirect measure of fatness. Studies using body fat measurement and disease stratification according to PCa stage found stronger associations between obesity and PCa. Leptin is a pleiotrophic hormone mainly synthesized by adipocytes that acts in peripheral organs such as the prostate. This article reviews obesity-associated leptin's pathophysiological role in PCa progression. PC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
33
0
4

Year Published

2006
2006
2010
2010

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 48 publications
(38 citation statements)
references
References 72 publications
1
33
0
4
Order By: Relevance
“…6,7,35 The effect of leptin on cancer cell in vitro has also been reported. Leptin stimulates the proliferation of breast, prostate and colorectal cancer cell lines.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…6,7,35 The effect of leptin on cancer cell in vitro has also been reported. Leptin stimulates the proliferation of breast, prostate and colorectal cancer cell lines.…”
Section: Discussionmentioning
confidence: 99%
“…2 In addition, obesity increases the risk of cancer developing in the prostate, colorectum, breast, endometrium and elsewhere. [3][4][5][6][7] Similarly, the risk of renal cell cancer is increased in patients with diabetes mellitus, a disease closely associated with obesity. 8 These observations are well correlated with the finding that the carcinogen-induced multiplicity of premalignant colonic lesions is increased in db/db obese and diabetic mice.…”
mentioning
confidence: 99%
“…42 IGF-1 is involved in angiogenesis, in the development of bone metastases, and in androgen-independent progression of prostate cancer 43 , and leptin induces cellular migration and growth-factor expression in hormone-resistant prostate cancer cells. 44,45 Thus, increased levels of IGF-1 and leptin in obese men may explain an apparent adverse effect of obesity on prostate cancer progression that leads to death. The observation of a positive association between obesity and risk of fatal prostate cancer suggests that, in this select group of particularly aggressive cancers, the adverse effects of excess body fat outweigh hormonal perturbations that potentially may decrease the risk of prostate cancer in obese men.…”
Section: Discussionmentioning
confidence: 99%
“…2 Adipose tissue may interact with multiple systems believed to have a role in prostate carcinogenesis, including CYP19 (aromatase) conversion of testosterone into estrogens and changes in immune, inflammatory and insulin responses (reviewed in Ribeiro 3 ). However, while obesity has been associated with prostate cancer mortality [4][5][6][7] and prostate-specific antigen (PSA) recurrence following primary treatment, [8][9][10] the relationship between obesity and prostate cancer risk remains poorly understood.…”
Section: Introductionmentioning
confidence: 99%